3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
3
Sarcoma
2
Rhabdomyosarcoma
2
Myelodysplastic Syndromes
2
Leukemia, Biphenotypic, Acute
2
Ganglioneuroblastoma
2
Sarcoma, Myeloid
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pleuropulmonary blastoma
1
PRETEXT I Hepatoblastoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Malignant mesenchymal tumor
1
Lymphoma, Large B-Cell, Diffuse
1
Localized Extraskeletal Ewing Sarcoma
1
Leukemia
1
Heart Failure
1
Drug-Related Side Effects and Adverse Reactions
1
Dendritic Cell Sarcoma, Interdigitating
1
Degradation of Top2b and Top2a in Human by Dexrazoxane
1
Cardiotoxicity
1
Burkitt Lymphoma
1
Blast Crisis
1
Interventions
Cyclophosphamide
7
Etoposide
5
Prednisone
4
Doxorubicin
4
Vincristine
3
romidepsin
2
pembrolizumab
2
etoposide phosphate
2
duvelisib
2
Melphalan
2
Brentuximab Vedotin
2
Azacitidine
2
10-propargyl-10-deazaaminopterin
2
tazemetostat
1
sodium-iodide symporter
1
ruxolitinib
1
prednylidene
1
glofitamab
1
fludarabine phosphate
1
fludarabine
1
deltacortene
1
cemiplimab
1
brincidofovir
1
belinostat
1
X-Rays
1
Whole-Body Irradiation
1
Valganciclovir
1
Therapeutics
1
Tacrolimus
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoblastic Lymphadenopathy
×
Dexrazoxane
×
1 year
×
Clear all
No trials found.